Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...

In trading on the Nasdaq as of 1:17 p.m. Central, Tempus' stock price was $60.65, up 3.2% from the previous day's close.

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...

In conjunction with its better-than-expected sales growth in the second quarter, Tempus AI raised its sales outlook for this ...

Tempus AI achieves strong revenue growth and beats expectations, but ongoing losses and execution risks temper enthusiasm.

Tempus AI, Inc. (NASDAQ:TEM) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 5.7% better than ...

Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects. Click here to read why TEM is a Hold.

Tempus AI TEM saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 66 to 78. Please watch ...

Tempus AI shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Although shares have retreated from their all-time high, those who bought shares one year ago are still looking at growth in ...

Tempus AI, a precision medicine company that, as its name implies, uses artificial intelligence to process medical data, popped in its stock market debut Friday, with shares jumping 15%.

At Tempus, the team is changing healthcare — and the world while they're at it With a data-first mentality, Tempus hopes to improve outcomes in the healthcare sector by collecting and pipelining a ...